Product Name

  • Name

    Etodolac

  • EINECS 629-689-1
  • CAS No. 41340-25-4
  • Article Data11
  • CAS DataBase
  • Density 1.193 g/cm3
  • Solubility 40mg/L(37 oC)
  • Melting Point 145-148 °C
  • Formula C17H21NO3
  • Boiling Point 507.9 °C at 760 mmHg
  • Molecular Weight 287.359
  • Flash Point 260.9 °C
  • Transport Information UN 3249
  • Appearance crystalline solid
  • Safety 22-36-45-26-36/37
  • Risk Codes 23/24/25-40-36-25-36/37/38
  • Molecular Structure Molecular Structure of 41340-25-4 (Etodolac)
  • Hazard Symbols ToxicT, IrritantXi
  • Synonyms (1,8-Diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indol-1-yl)acetic acid;1,3,4,9-Tetrahydro-1,8-diethylpyrano(3,4-b)indole-1-acetic acid;Prestwick_209;Pyrano(3,4-b)indole-1-acetic acid, 1,8-diethyl-1,3,4,9-tetrahydro-;Lodine;Lodine (TN);Ultradol;{Pyrano[3,} 4-b]indole-1-acetic acid, 1,8-diethyl-1,3,4,9-tetrahydro-;{1,8-Diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indole-1-acetic} acid;Etodolacum [INN-Latin];1,8-Diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indole-1-acetic acid;Etodolaco [INN-Spanish];Pyrano(3,4-b)indole-1-acetic acid, 1,3,4,9-tetrahydro-1,8-diethyl-;Pyrano[3,4-b]indole-1-acetic acid,1,8-diethyl-1,3,4,9-tetrahydro-;Etodolac (JAN/USP);Etodolic acid;AY 24236;Etodolac Acid;
  • PSA 62.32000
  • LogP 3.38300

Synthetic route

7-ethyl-2-(1H-indol-3-yl)ethan-1-ol
41340-36-7

7-ethyl-2-(1H-indol-3-yl)ethan-1-ol

ethyl propanoylacetate
4949-44-4

ethyl propanoylacetate

etodolac
41340-25-4

etodolac

Conditions
ConditionsYield
(i) TsOH, benzene, (ii) aq. NaOH, EtOH; Multistep reaction;
2,2-Dimethyl-propionic acid 2-(1,8-diethyl-1,3,4,9-tetrahydro-pyrano[3,4-b]indol-1-yl)-acetoxymethyl ester

2,2-Dimethyl-propionic acid 2-(1,8-diethyl-1,3,4,9-tetrahydro-pyrano[3,4-b]indol-1-yl)-acetoxymethyl ester

A

2,2-Dimethyl-propionic acid 2-((S)-1,8-diethyl-1,3,4,9-tetrahydro-pyrano[3,4-b]indol-1-yl)-acetoxymethyl ester

2,2-Dimethyl-propionic acid 2-((S)-1,8-diethyl-1,3,4,9-tetrahydro-pyrano[3,4-b]indol-1-yl)-acetoxymethyl ester

B

etodolac
41340-25-4

etodolac

Conditions
ConditionsYield
With Lipase QL In di-isopropyl ether; water for 192h; Product distribution; Ambient temperature; various lipase enzymes;
(R)-etodolac
87226-41-3

(R)-etodolac

etodolac
41340-25-4

etodolac

Conditions
ConditionsYield
With tin(IV) chloride In tetrahydrofuran; dichloromethane for 4h; Heating / reflux;
sulfuric acid In isopropyl alcohol at 20℃; for 23h; Product distribution / selectivity;
(R)-etodolac
87226-41-3

(R)-etodolac

(S)-etodolac
87249-11-4

(S)-etodolac

etodolac
41340-25-4

etodolac

Conditions
ConditionsYield
With tin(IV) chloride In dichloromethane at 20℃; for 2h;
Stage #1: (R)-etodolac; (S)-etodolac In dichloromethane at 20℃; for 2h;
Stage #2: With sodium hydroxide; formic acid at 0℃; for 1h; pH=5;
(S)-etodolac
87249-11-4

(S)-etodolac

etodolac
41340-25-4

etodolac

Conditions
ConditionsYield
sulfuric acid In isopropyl alcohol at 20℃; for 4 - 18h; Product distribution / selectivity;
boron trifluoride diethyl etherate In isopropyl alcohol at 20℃; for 15h; Product distribution / selectivity;
7-ethyl-2-(1H-indol-3-yl)ethan-1-ol
41340-36-7

7-ethyl-2-(1H-indol-3-yl)ethan-1-ol

methyl propanoyl acetate
30414-53-0

methyl propanoyl acetate

etodolac
41340-25-4

etodolac

Conditions
ConditionsYield
With sulfuric acid In methanol Pictet-Spengler Synthesis;
etodolac
41340-25-4

etodolac

(+/-)-2-(1,8-diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indol-1-yl)ethanol
200880-25-7

(+/-)-2-(1,8-diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indol-1-yl)ethanol

Conditions
ConditionsYield
With LiAlH4 In tetrahydrofuran; hexane; ethyl acetate98%
With lithium aluminium tetrahydride In tetrahydrofuran at 20℃; for 12h;92%
N-tert-butoxycarbonyl-3-aminopropanol
58885-58-8

N-tert-butoxycarbonyl-3-aminopropanol

etodolac
41340-25-4

etodolac

Boc-aminopropanol-etodolac

Boc-aminopropanol-etodolac

Conditions
ConditionsYield
With dmap; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In dichloromethane; N,N-dimethyl-formamide at 20℃; Cooling with ice;96%
Magnolol
528-43-8

Magnolol

etodolac
41340-25-4

etodolac

5,5'-diallyl-2'-hydroxy-[1,1'-biphenyl]-2-yl-2-(1,8-diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indol-1-yl)acetate

5,5'-diallyl-2'-hydroxy-[1,1'-biphenyl]-2-yl-2-(1,8-diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indol-1-yl)acetate

Conditions
ConditionsYield
With dmap; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In dichloromethane at 20℃; for 1h;90%
With dmap In dichloromethane at 25 - 30℃;90%
acetic acid
64-19-7

acetic acid

etodolac
41340-25-4

etodolac

2-(dimethylamino)ethyl 1,8-diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indole-1-acetamide acetate

2-(dimethylamino)ethyl 1,8-diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indole-1-acetamide acetate

Conditions
ConditionsYield
Stage #1: N,N-dimethylethylenediamine; etodolac With O-(benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium tetrafluoroborate; triethylamine In acetonitrile at 20℃; for 3h;
Stage #2: acetic acid In ethyl acetate
89.4%
2,2,2,-trichloroethoxycarbonyl azide

2,2,2,-trichloroethoxycarbonyl azide

etodolac
41340-25-4

etodolac

2,2,2-trichloroethyl ((1,8-diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indol-1-yl)methyl)carbamate

2,2,2-trichloroethyl ((1,8-diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indol-1-yl)methyl)carbamate

Conditions
ConditionsYield
With dmap; copper diacetate In acetonitrile at 80℃; for 3h; Schlenk technique; Sealed tube;86%
methanol
67-56-1

methanol

etodolac
41340-25-4

etodolac

methyl 1,8-diethyl-1,3,4,9-tetrahydropyrano(3,4-b)-indole-1-acetate

methyl 1,8-diethyl-1,3,4,9-tetrahydropyrano(3,4-b)-indole-1-acetate

Conditions
ConditionsYield
With sulfuric acid for 8h; Reflux;85%
With sulfuric acid for 3h; Reflux;66%
With sulfuric acid
With sulfuric acid for 3h; Reflux;
3-hydroxypropyl selenocyanate
115423-27-3

3-hydroxypropyl selenocyanate

etodolac
41340-25-4

etodolac

3-selenocyanatopropyl 2-(1,8-diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indol-1-yl)acetate

3-selenocyanatopropyl 2-(1,8-diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indol-1-yl)acetate

Conditions
ConditionsYield
Stage #1: etodolac In N,N-dimethyl-formamide at 25℃; for 0.5h;
Stage #2: 3-hydroxypropyl selenocyanate In N,N-dimethyl-formamide at 25℃; for 16h;
85%
thymol
89-83-8

thymol

etodolac
41340-25-4

etodolac

2-isopropyl-5-methylphenyl 2-(1,8‑diethyl-4,9-dihydro-3Hpyrano[3,4-b]indol-1-yl)acetate

2-isopropyl-5-methylphenyl 2-(1,8‑diethyl-4,9-dihydro-3Hpyrano[3,4-b]indol-1-yl)acetate

Conditions
ConditionsYield
With dmap; dicyclohexyl-carbodiimide In dichloromethane at 25℃; for 72h; Steglich Esterification;83.5%
etodolac
41340-25-4

etodolac

2-(1,8-diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indol-1-yl)acetamide
591752-31-7

2-(1,8-diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indol-1-yl)acetamide

Conditions
ConditionsYield
Stage #1: etodolac With oxalyl dichloride at 20℃;
Stage #2: With ammonium hydroxide
82.5%
curcumin
458-37-7

curcumin

etodolac
41340-25-4

etodolac

((1E,6E)-3,5-dioxohepta-1,6-diene-1,7-diyl)bis(2-methoxy-4,1-phenylene) bis(2-(1,8-diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indol-1-yl)acetate)

((1E,6E)-3,5-dioxohepta-1,6-diene-1,7-diyl)bis(2-methoxy-4,1-phenylene) bis(2-(1,8-diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indol-1-yl)acetate)

Conditions
ConditionsYield
With dmap; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In dichloromethane at 20℃; for 1h;80%
curcumin
458-37-7

curcumin

etodolac
41340-25-4

etodolac

A

C36H35NO8

C36H35NO8

B

C51H50N2O10

C51H50N2O10

Conditions
ConditionsYield
With dmap In dichloromethane at 25 - 30℃;A 56%
B 80%
Magnolol
528-43-8

Magnolol

etodolac
41340-25-4

etodolac

5,5'-diallyl-[1,1'-biphenyl]-2,2'-diyl-bis(2-(1,8-diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indol-1-yl)acetate)

5,5'-diallyl-[1,1'-biphenyl]-2,2'-diyl-bis(2-(1,8-diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indol-1-yl)acetate)

Conditions
ConditionsYield
With dmap; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In dichloromethane at 20℃; for 1h;78%
With dmap In dichloromethane at 25 - 30℃;78%
benzyl bromide
100-39-0

benzyl bromide

etodolac
41340-25-4

etodolac

2-(9-benzyl-1,8-diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indol-1-yl)acetic acid

2-(9-benzyl-1,8-diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indol-1-yl)acetic acid

Conditions
ConditionsYield
With sodium hydride In tetrahydrofuran at 50℃; for 2h;73%
1-selenocyano-2-ethylamine hydrobromide

1-selenocyano-2-ethylamine hydrobromide

etodolac
41340-25-4

etodolac

2-(1,8-diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indol-1-yl)-N-(2-selenocyanatoethyl)acetamide

2-(1,8-diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indol-1-yl)-N-(2-selenocyanatoethyl)acetamide

Conditions
ConditionsYield
Stage #1: etodolac With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; triethylamine In dichloromethane; N,N-dimethyl-formamide at 25℃; for 0.5h;
Stage #2: 1-selenocyano-2-ethylamine hydrobromide In dichloromethane; N,N-dimethyl-formamide at 25℃; for 16h;
72%
2-azido-1-phenylethan-1-one
1816-88-2

2-azido-1-phenylethan-1-one

etodolac
41340-25-4

etodolac

2-(1,8-diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indol-1-yl)-N-(2-oxo-2-phenylethyl)acetamide

2-(1,8-diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indol-1-yl)-N-(2-oxo-2-phenylethyl)acetamide

Conditions
ConditionsYield
In 1,2-dichloro-ethane at 110℃; for 10h; Sealed tube;72%
2-selenocyanatopropanamine hydrobromide

2-selenocyanatopropanamine hydrobromide

etodolac
41340-25-4

etodolac

2-(1,8-diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indol-1-yl)-N-(3-selenocyanatopropyl)acetamide

2-(1,8-diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indol-1-yl)-N-(3-selenocyanatopropyl)acetamide

Conditions
ConditionsYield
Stage #1: etodolac With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; triethylamine In dichloromethane; N,N-dimethyl-formamide at 25℃; for 0.5h; Inert atmosphere;
Stage #2: 2-selenocyanatopropanamine hydrobromide In dichloromethane; N,N-dimethyl-formamide at 25℃; for 16h; Inert atmosphere;
65%
Stage #1: etodolac With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; triethylamine In dichloromethane; N,N-dimethyl-formamide at 25℃; for 0.5h;
Stage #2: 2-selenocyanatopropanamine hydrobromide In dichloromethane; N,N-dimethyl-formamide at 25℃; for 16h;
60%
etodolac
41340-25-4

etodolac

C17H23NO2

C17H23NO2

Conditions
ConditionsYield
With lithium aluminium tetrahydride In tetrahydrofuran at 20℃; Inert atmosphere;59%
{(1R,2R)-cyclohexane-1,2-diamine}dichloridoplatinum(II)
38780-40-4, 52691-24-4, 61848-70-2, 61848-66-6, 61848-62-2

{(1R,2R)-cyclohexane-1,2-diamine}dichloridoplatinum(II)

etodolac
41340-25-4

etodolac

C23H34ClN3O3Pt

C23H34ClN3O3Pt

Conditions
ConditionsYield
With sodium carbonate; silver nitrate In N,N-dimethyl-formamide at 20℃; for 24h; Darkness;52%
dihydrocapsaicin
19408-84-5

dihydrocapsaicin

etodolac
41340-25-4

etodolac

(1,8-diethyl-1,3,4,9-tetrahydro-pyrano[3,4-b]indol-1-yl)-acetic acid 2-methoxy-4-[(8-methyl-nonanoylamino)-methyl]-phenyl ester
1224429-03-1

(1,8-diethyl-1,3,4,9-tetrahydro-pyrano[3,4-b]indol-1-yl)-acetic acid 2-methoxy-4-[(8-methyl-nonanoylamino)-methyl]-phenyl ester

Conditions
ConditionsYield
With dmap; dicyclohexyl-carbodiimide In dichloromethane at 30 - 35℃;49.6%
Propargylamine
2450-71-7

Propargylamine

etodolac
41340-25-4

etodolac

C20H24N2O2

C20H24N2O2

Conditions
ConditionsYield
Stage #1: etodolac With triethylamine In tetrahydrofuran at -50℃; for 1h; Inert atmosphere;
Stage #2: Propargylamine With isobutyl chloroformate In tetrahydrofuran at -50 - 20℃; for 13h; Inert atmosphere;
46.8%
ammonium hydroxide
1336-21-6

ammonium hydroxide

oxalyl dichloride
79-37-8

oxalyl dichloride

etodolac
41340-25-4

etodolac

2-(1,8-diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indol-1-yl)acetamide
591752-31-7

2-(1,8-diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indol-1-yl)acetamide

Conditions
ConditionsYield
N,N-dimethyl-formamide In tetrahydrofuran; hexane; dichloromethane; ethyl acetate35%
potassium ethyl methylmalonate
103362-70-5

potassium ethyl methylmalonate

etodolac
41340-25-4

etodolac

C19H23NO4

C19H23NO4

Conditions
ConditionsYield
Stage #1: etodolac With 1,1'-carbonyldiimidazole Inert atmosphere;
Stage #2: potassium ethyl methylmalonate With magnesium chloride Inert atmosphere;
35%
capsaicin
404-86-4

capsaicin

etodolac
41340-25-4

etodolac

(1,8-diethyl-1,3,4,9-tetrahydro-pyrano[3,4-b]indol-1-yl)-acetic acid 2-methoxy-4-[(8-methyl-non-6-enoylamino)-methyl]-phenyl ester
1224429-01-9

(1,8-diethyl-1,3,4,9-tetrahydro-pyrano[3,4-b]indol-1-yl)-acetic acid 2-methoxy-4-[(8-methyl-non-6-enoylamino)-methyl]-phenyl ester

Conditions
ConditionsYield
With dmap; dicyclohexyl-carbodiimide In dichloromethane at 30 - 35℃;30.2%
etodolac
41340-25-4

etodolac

A

1,8-diethyl-4-oxo-1,3,4,9-tetrahydropyrano[3,4-b]-indole-1-acetic acid
111478-86-5

1,8-diethyl-4-oxo-1,3,4,9-tetrahydropyrano[3,4-b]-indole-1-acetic acid

B

1,8-diethyl-4-hydroxy-1,3,4,9-tetrahydropyrano[3,4-b]-indole-1-acetic acid

1,8-diethyl-4-hydroxy-1,3,4,9-tetrahydropyrano[3,4-b]-indole-1-acetic acid

Conditions
ConditionsYield
With iodosylbenzene; Cl8TTPFe(III)Cl In dichloromethane at 20℃; for 2h;A 20%
B 25%
etodolac
41340-25-4

etodolac

methyl iodide
74-88-4

methyl iodide

A

3a,10-diethyl-5,6,6a,11-tetrahydro-6a-methylfuro<3',2'2,3>pyrano<3,4-b>indol-2(3H)-one
114737-77-8

3a,10-diethyl-5,6,6a,11-tetrahydro-6a-methylfuro<3',2'2,3>pyrano<3,4-b>indol-2(3H)-one

B

2-(1,8-diethyl-9-methyl-1,3,4,9-tetrahydro-pyrano[3,4-b]indol-1-yl)acetic acid
114720-05-7

2-(1,8-diethyl-9-methyl-1,3,4,9-tetrahydro-pyrano[3,4-b]indol-1-yl)acetic acid

Conditions
ConditionsYield
With sodium hydride In tetrahydrofuran at 50℃; for 2h;A 20%
B 16%
etodolac
41340-25-4

etodolac

7-ethyl-2-(1-methylenepropyl)-1H-indole-3-ethanol

7-ethyl-2-(1-methylenepropyl)-1H-indole-3-ethanol

Conditions
ConditionsYield
In methanol for 72h; Heating; pH 6.0;20%
(OC-6-33)-(diammine)dichloridodihydroxidoplatinum(IV)
125074-46-6, 31246-62-5, 31246-63-6, 31246-66-9, 53261-25-9

(OC-6-33)-(diammine)dichloridodihydroxidoplatinum(IV)

etodolac
41340-25-4

etodolac

C34H46Cl2N4O6Pt

C34H46Cl2N4O6Pt

Conditions
ConditionsYield
With triethylamine; O‐(1H‐benzotriazol‐1‐yl)‐N,N,N′,N′‐tetramethyluronium tetrafluoroborate In N,N-dimethyl-formamide at 20℃; for 24h; Darkness;19.5%
etodolac
41340-25-4

etodolac

A

7-ethyl-2-(1H-indol-3-yl)ethan-1-ol
41340-36-7

7-ethyl-2-(1H-indol-3-yl)ethan-1-ol

B

7-ethyl-2-(1-methyl-1-propenyl)-1H-indole-3-ethanol

7-ethyl-2-(1-methyl-1-propenyl)-1H-indole-3-ethanol

C

7-ethyl-2-(1-methylenepropyl)-1H-indole-3-ethanol

7-ethyl-2-(1-methylenepropyl)-1H-indole-3-ethanol

D

1,8-diethyl-1-methyl-1,3,4,9-tetrahydropyrano-<3,4-b>indole

1,8-diethyl-1-methyl-1,3,4,9-tetrahydropyrano-<3,4-b>indole

Conditions
ConditionsYield
With hydrogenchloride In methanol; water at 85℃; for 18h; Product distribution; Rate constant; Thermodynamic data; Ea, ΔS<*>, mechanism of etodolac degradation in aqueous solutionsat various temperatures (75-905 deg C), time and pH, effect of pH and temperature, catalytic effect of buffer system;
etodolac
41340-25-4

etodolac

(+)-etodolac
87249-11-4

(+)-etodolac

Etodolac Chemical Properties

Molecule structure of Etodolac (CAS NO.41340-25-4):

IUPAC Name: 2-(1,8-Diethyl-4,9-dihydro-3H-pyrano[3,4-b]indol-1-yl)acetic acid 
Molecular Weight: 287.35354 g/mol
Molecular Formula: C17H21NO3 
Density: 1.193 g/cm
Melting Point:145-148 °C
Boiling Point: 507.9 °C at 760 mmHg 
Flash Point: 260.9 °C
Index of Refraction: 1.596
Molar Refractivity: 81.98 cm3
Molar Volume: 240.7 cm3
Surface Tension: 53.9 dyne/cm 
Enthalpy of Vaporization: 81.93 kJ/mol
Vapour Pressure: 3.88E-11 mmHg at 25 °C 
Storage Temp.: 2-8 °C
XLogP3-AA: 2.8
H-Bond Donor: 2
H-Bond Acceptor: 3
Rotatable Bond Count: 4
Exact Mass: 287.152144
MonoIsotopic Mass: 287.152144
Topological Polar Surface Area: 62.3
Heavy Atom Count: 21
Canonical SMILES: CCC1=CC=CC2=C1NC3=C2CCOC3(CC)CC(=O)O
InChI: InChI=1S/C17H21NO3/c1-3-11-6-5-7-12-13-8-9-21-17(4-2,0-14(19)20)16(13)18-15(11)12/h5-7,18H,3-4,8-10H2,1-2H3,(H,19,20)
InChIKey: NNYBQONXHNTVIJ-UHFFFAOYSA-N
Product Categories: APIs; Intermediates & Fine Chemicals; Pharmaceuticals

Etodolac Uses

 Etodolac (CAS NO.41340-25-4) is a non-steroidal anti-inflammatory drug (NSAID). It is used to anti-inflammatory.

Etodolac Production

 Etodolac is manufactured by Shire under the trade name Lodine SR and by Meda Pharmaceuticals under the name Eccoxolac . Non-propriety etodolac is also available.

Etodolac Toxicity Data With Reference

Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
dog LDLo oral > 4gm/kg (4000mg/kg) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD

BEHAVIORAL: FOOD INTAKE (ANIMAL)

GASTROINTESTINAL: "HYPERMOTILITY, DIARRHEA"
Oyo Yakuri. Pharmacometrics. Vol. 40, Pg. 469, 1990.
mouse LD50 intraperitoneal 338mg/kg (338mg/kg) LUNGS, THORAX, OR RESPIRATION: DYSPNEA

GASTROINTESTINAL: "HYPERMOTILITY, DIARRHEA"
Oyo Yakuri. Pharmacometrics. Vol. 40, Pg. 469, 1990.
mouse LD50 oral 593mg/kg (593mg/kg) LUNGS, THORAX, OR RESPIRATION: DYSPNEA

GASTROINTESTINAL: "HYPERMOTILITY, DIARRHEA"
Oyo Yakuri. Pharmacometrics. Vol. 40, Pg. 469, 1990.
mouse LD50 subcutaneous 502mg/kg (502mg/kg) LUNGS, THORAX, OR RESPIRATION: DYSPNEA

GASTROINTESTINAL: "HYPERMOTILITY, DIARRHEA"
Oyo Yakuri. Pharmacometrics. Vol. 40, Pg. 469, 1990.
rat LD50 intraperitoneal 100mg/kg (100mg/kg) LUNGS, THORAX, OR RESPIRATION: DYSPNEA

GASTROINTESTINAL: "HYPERMOTILITY, DIARRHEA"
Oyo Yakuri. Pharmacometrics. Vol. 40, Pg. 469, 1990.
rat LD50 oral 94mg/kg (94mg/kg) LUNGS, THORAX, OR RESPIRATION: DYSPNEA

GASTROINTESTINAL: "HYPERMOTILITY, DIARRHEA"
Oyo Yakuri. Pharmacometrics. Vol. 40, Pg. 469, 1990.
rat LD50 subcutaneous 113mg/kg (113mg/kg) LUNGS, THORAX, OR RESPIRATION: DYSPNEA

GASTROINTESTINAL: "HYPERMOTILITY, DIARRHEA"
Oyo Yakuri. Pharmacometrics. Vol. 40, Pg. 469, 1990.

Etodolac Safety Profile

Hazard Codes: ToxicT, IrritantXi
Risk Statements: 23/24/25-40-36-25-36/37/38 
R23/24/25: Toxic by inhalation, in contact with skin and if swallowed. 
R40: Limited evidence of a carcinogenic effect. 
R36: Irritating to eyes. 
R25: Toxic if swallowed. 
R36/37/38: Irritating to eyes, respiratory system and skin.
Safety Statements: 22-36-45-26-36/37 
S22: Do not breathe dust. 
S36: Wear suitable protective clothing.
S45: In case of accident or if you feel unwell, seek medical advice immediately (show the label whenever possible.)
S26: In case of contact with eyes, rinse immediately with plenty of water and seek medical advice. 
S36/37: Wear suitable protective clothing and gloves.
RIDADR: 3249
WGK Germany: 3
RTECS: UQ0360000
HazardClass: 6.1(b)
PackingGroup: III

Etodolac Specification

 Etodolac (CAS NO.41340-25-4) is also named as (+-)-1,8-Diethyl-1,3,4,9-tetrahydropyrano(3,4-b)indole-1-acetic acid ; 1,3,4,9-Tetrahydro-1,8-diethylpyrano(3,4-b)indole-1-acetic acid ; 1,8-Diethyl-1,3,4,9-tetrahydropyrano(3,4-b)indole-1-acetic acid ; AY 24236 ; CCRIS 3923 ; Etodolaco ; Etodolaco [INN-Spanish] ; Etodolacum ; Etodolacum [INN-Latin] ; Etodolic acid ; Lodine ; Lodine XL ; NSC 282126 ; Pyrano(3,4-b)indole-1-acetic acid, 1,8-diethyl-1,3,4,9-tetrahydro-(+-)- ; UNII-2M36281008 ; Ultradol . Etodolac (CAS NO.41340-25-4) is crystalline solid. Etodolac belongs to a class of drugs called nonsteroidal anti-inflammatory drugs (NSAIDs).

Post buying leads

About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia

Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog

©2008 LookChem.com,License: ICP

NO.:Zhejiang16009103

complaints:service@lookchem.com Desktop View